🌟 𝗧𝗵𝗲 𝗚𝗥𝗘𝗚 𝗼𝗳𝗳𝗶𝗰𝗶𝗮𝗹 𝘄𝗲𝗯𝘀𝗶𝘁𝗲 𝗶𝘀 𝗻𝗼𝘄 𝗮𝘃𝗮𝗶𝗹𝗮𝗯𝗹𝗲! Discover a 𝗯𝗿𝗼𝗮𝗱𝗲𝗿 𝗿𝗮𝗻𝗴𝗲 𝗼𝗳 𝗰𝗼𝗻𝘁𝗲𝗻𝘁 and 𝗱𝗲𝗱𝗶𝗰𝗮𝘁𝗲𝗱 𝘀𝗲𝗰𝘁𝗶𝗼𝗻𝘀 designed to support the project’s progress and enhance communication and stakeholder engagement. 🌐 The GREG website is 𝗱𝘆𝗻𝗮𝗺𝗶𝗰 and will be 𝗰𝗼𝗻𝘁𝗶𝗻𝘂𝗼𝘂𝘀𝗹𝘆 𝘂𝗽𝗱𝗮𝘁𝗲𝗱 𝘄𝗶𝘁𝗵 𝗻𝗲𝘄 𝗰𝗼𝗻𝘁𝗲𝗻𝘁 throughout the project — giving you timely access to the latest information, news, resources, and insights. 👉 𝗧𝗮𝗸𝗲 𝗮 𝗹𝗼𝗼𝗸 𝗮𝗻𝗱 𝗷𝗼𝗶𝗻 𝘂𝘀 𝗼𝗻 𝘁𝗵𝗶𝘀 𝗷𝗼𝘂𝗿𝗻𝗲𝘆: www.ihi-greg.eu #IHI_GREG #RWE #Healthcare #Innovation
IHI GREG
Research Services
Creating and refining guidelines and tools to generate and use Real-World Evidence for better decision-making in Europe.
About us
GREG - Testing, improving, and co-creating Guidance and Tools for Real World Evidence Generation and Use for Decision-Making in Europe. GREG is a public-private partnership supported by the Innovative Health Initiative Joint Undertaking (IHI JU), set to revolutionise Real-World Evidence (RWE) practices in Europe. The GREG initiative aims to create, test, and share practical, evidence-based guidance and tools to help generate and use RWE. By enhancing how RWE informs the development and evaluation of medicines, medical devices, and drug-device combinations, we will support better decision-making for regulators and Health Technology Assessment (HTA) bodies. Starting in May 2025, the GREG project will unfold over the next five years, bringing together 29 partner organisations from 15 countries. The GREG consortium is uniquely positioned to make a significant impact on European RWE practices. Led by Erasmus University Medical Center (The Netherlands) as the Coordinator, Novo Nordisk (Denmark) as the Project Lead, and Sanofi (France) as the Co-Lead, with support from the University of Oxford (United Kingdom), we are ready to make a difference. Curious to see how we are transforming healthcare? Follow us to stay updated and be part of the journey! #IHI_GREG
- Website
-
www.ihi-greg.eu
External link for IHI GREG
- Industry
- Research Services
- Company size
- 51-200 employees
- Type
- Partnership
Updates
-
We’re excited to share our TV Connect session from ESC Congress 2025! "RWE and the GREG Initiative: Bridging regulation and data innovation in cardiology" For those who could not attend live, this is a great opportunity to revisit the key insights and discussions we presented with Lars Wallentin and Tom Melvin. ▶️ Watch the full session here on our GREG YouTube Channel! If you enjoy the content, don’t forget to subscribe to GREG on YouTube so you won’t miss future updates, talks, recordings, and highlights from our journey in revolutionising RWE practices and transforming healthcare. 👉 Subscribe here: https://lnkd.in/etdmRw9r https://lnkd.in/esYgUQy2 #ESCCongress #Cardiology #Research #Innovation #IHI_GREG #RWE #HTA #Healthcare
ESC TV Connect - RWE and the GREG Initiative: Bridging regulation and data innovation in cardiology
https://www.youtube.com/
-
What an inspiring session today at #ESCCongress! The discussion on Real-World Evidence and the IHI GREG initiative truly highlighted how bridging regulatory science and data innovation can transform cardiovascular care. Key takeaways: 🔹 Real-world data is not just complementary to clinical trials — it’s essential for shaping smarter, faster, and more patient-centred decisions. 🔹 Collaboration between regulators, clinicians, and innovators is the only way to translate insights into impact. 🔹 Initiatives like GREG are paving the way for a future where evidence and innovation move hand-in-hand. A special thanks to our speakers Dr. Lars Wallentin and Prof. Tom Melvin, and to Prof. Alan Fraser for moderating the session. Your insights made this a truly impactful exchange and together we are building a stronger foundation for evidence-driven cardiology! #IHI_GREG #RWE #HTA #Healthcare #Innovation #Cardiology #ESCCongress
-
-
-
-
-
+2
-
-
Join us live from 𝐄𝐒𝐂 𝐂𝐨𝐧𝐠𝐫𝐞𝐬𝐬 𝟐𝟎𝟐𝟓 for an exciting session: 🗓 "𝗥𝗲𝗮𝗹-𝘄𝗼𝗿𝗹𝗱 𝗲𝘃𝗶𝗱𝗲𝗻𝗰𝗲 𝗮𝗻𝗱 𝘁𝗵𝗲 𝗚𝗥𝗘𝗚 𝗶𝗻𝗶𝘁𝗶𝗮𝘁𝗶𝘃𝗲: 𝗕𝗿𝗶𝗱𝗴𝗶𝗻𝗴 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗱𝗮𝘁𝗮 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗶𝗻 𝗰𝗮𝗿𝗱𝗶𝗼𝗹𝗼𝗴𝘆" 📍 ESC TV Connect (Hall 6) 🕛 𝟐𝟗 𝐀𝐮𝐠𝐮𝐬𝐭 | 𝟏𝟐:𝟏𝟓 – 𝟏𝟐:𝟒𝟓 We’re diving into how 𝗿𝗲𝗮𝗹-𝘄𝗼𝗿𝗹𝗱 𝗱𝗮𝘁𝗮 is transforming cardiovascular care—and how initiatives like IHI GREG are connecting the dots between 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝘀𝗰𝗶𝗲𝗻𝗰𝗲 and 𝗱𝗮𝘁𝗮 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻. 📸 Here’s a sneak peek from the making-of! Don't miss the discussion—insights, impact, and inspiration from the heart of ESC. #IHI_GREG #RWE #HTA #Healthcare #Innovation #Cardiology #ESCCongress
-
-
📢 𝗚𝗥𝗘𝗚 𝗧𝗩 𝗖𝗼𝗻𝗻𝗲𝗰𝘁 𝗦𝗲𝘀𝘀𝗶𝗼𝗻 𝗮𝘁 𝗘𝗦𝗖 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 𝟮𝟬𝟮𝟱! Join us this 𝗙𝗿𝗶𝗱𝗮𝘆, 𝟮𝟵 𝗔𝘂𝗴𝘂𝘀𝘁, at the #ESCCongress in Madrid for a session on 𝗥𝗲𝗮𝗹-𝗪𝗼𝗿𝗹𝗱 𝗘𝘃𝗶𝗱𝗲𝗻𝗰𝗲 𝗮𝗻𝗱 𝘁𝗵𝗲 IHI GREG 𝗜𝗻𝗶𝘁𝗶𝗮𝘁𝗶𝘃𝗲: 𝗕𝗿𝗶𝗱𝗴𝗶𝗻𝗴 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗗𝗮𝘁𝗮 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗶𝗻 𝗖𝗮𝗿𝗱𝗶𝗼𝗹𝗼𝗴𝘆. Gain key insights from leading experts Dr. Lars Wallentin, Prof. Tom Melvin, and Dr. Despina Voulgaraki, as they explore the evolving regulatory acceptability of real-world and registry data in the context of the Medical Device Regulation (MDR). This session will also highlight 𝗵𝗼𝘄 𝗚𝗥𝗘𝗚 𝗮𝗻𝗱 𝗥𝗲𝗮𝗹-𝗪𝗼𝗿𝗹𝗱 𝗘𝘃𝗶𝗱𝗲𝗻𝗰𝗲 𝗰𝗮𝗻 𝘀𝘁𝗿𝗲𝗻𝗴𝘁𝗵𝗲𝗻 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗰𝗼𝗻𝗳𝗶𝗱𝗲𝗻𝗰𝗲 𝗮𝗻𝗱 𝗱𝗲𝗹𝗶𝘃𝗲𝗿 𝗺𝗲𝗮𝗻𝗶𝗻𝗴𝗳𝘂𝗹 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗶𝗺𝗽𝗮𝗰𝘁 𝗶𝗻 𝗰𝗮𝗿𝗱𝗶𝗼𝗹𝗼𝗴𝘆 — by addressing key challenges and advances in data availability, quality, and standardisation. 👉 𝗙𝗼𝗿 𝗺𝗼𝗿𝗲 𝗶𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝘀𝗲𝘀𝘀𝗶𝗼𝗻 𝗱𝗲𝘁𝗮𝗶𝗹𝘀, 𝘃𝗶𝘀𝗶𝘁: https://lnkd.in/dHqqq84c #IHI_GREG #RWE #HTA #Healthcare #Innovation #Cardiology
-
-
IHI GREG reposted this
👩💻 Real-world #HealthData and evidence (RWD/RWE) have immense potential to advance the development and evaluation of medicines, medical devices, and drug-device combinations. Guidance on how this could work exists, but is high level, not evidence-based, and implementing it in practice is far from easy. 👋 Meet new project IHI GREG, which aims to to turn this situation around by generating guidance and tools to boost the impact of #RWE in Europe. Find out more 👉 https://europa.eu/!nGJj9x #IHITransformingHealth #HorizonEU
-
📢 IHI GREG is featured in The Pharma Letter for its purpose of tackling long-standing challenges around the use of real-world data and evidence in medicines, medical devices, and drug-device combinations. By connecting experts in research, policy, regulatory affairs, and healthcare, we strive to promote a coordinated, transparent approach to real-world evidence (RWE). Our goal? To strengthen evidence-based decision-making across European health systems and beyond. 📄 Read the full article here and get to know the project and its Consortium better: https://lnkd.in/e_ADhQAY
-
IHI GREG reposted this
🗞️ Our July newsletter is out now at https://europa.eu/!qrBPCb 📰 Highlights include a story on how our projects AD-RIDDLE and IHI-PROMINENT are channelling #HealthEconomics to advance #Alzheimer diagnosis and treatment, plus we meet new IHI projects VIROMARKERS and IHI GREG and we showcase our latest highlights brochure... #IHITransformingHealth #HorizonEU
-
-
📢 𝗜𝗛𝗜 𝗚𝗥𝗘𝗚 𝗶𝘀 𝗵𝗲𝗮𝗱𝗶𝗻𝗴 𝘁𝗼 𝗘𝗦𝗖 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 𝟮𝟬𝟮𝟱 𝗶𝗻 𝗠𝗮𝗱𝗿𝗶𝗱! Join us to learn more about our work and how we’re advancing the use of Real-World Evidence to support healthcare innovation and informed decision-making across Europe. This will be a valuable opportunity to engage with stakeholders and contribute to discussions shaping the future of healthcare and cardiovascular medicine. #IHI_GREG #RWE #HTA #Healthcare #Innovation #ESCCongress #WCCardio
-
IHI GREG reposted this
Elevating Partnerships: Real-World Data/Evidence - Boost your Capacities! #PEOF2025 Our goals during this session is to ensure we: ✅ Understand what Real World Data (RWD) & Real World Evidence (RWE) are, including their sources & how they differ from traditional clinical trial data ✅ Identify challenges & limitations of RWD such as data quality & bias & ethical considerations ✅ Recognise the value & applications of RWE particularly in Regulatory, HTA, & healthcare decision-making ✅ Clarify the role of patients in contributing to & shaping meaningful RWD & RWE Some key takeaways 🔑 👉 What can we learn from RWE? 💡 Help identify treatment patterns 💡 Identify high risk patient groups 💡 Evaluate cost effectiveness of different treatments 👀 Challenges in RWE? 🔍 Rare diseases - small sample sizes, hard to identify target populations, inconsistent data models & lack of standards 🔍 Medical Devices & Interventions - lack of detailed data, missing links between devices & outcomes, tech evolves quickly 🔍 Digital Health Technologies - unclear evaluation frameworks, data privacy & consent concerns, inconsistent data collection & analysis 🤓 Best practices for transparent RWE studies? ✅ Study planning - define research question, select appropriate data sources ✅ Study conduct - choose right design & analytical methods, minimize risk of bias, ✅ Reporting - document comprehensively, define study methods clearly ✅ Interpreting & communicating results - communicate findings clearly ❓ Why RWE matters? 💯 Supports regulatory decisions 💯 Enhances healthcare decision-making 💯 Improves patient outcomes 🫶 How patients shape RWE/RWD? ✅ Generate health data through wearables, mobile apps & home monitoring devices ✅ Enroll in registries & participate in studies add to disease specific databases ✅ Design research by sharing input on data collection methods ✅ Advocate for ethical use & transparency use of their data ✅ Feedback on study findings & validate findings based on experiences ✅ Engage with advocacy groups & promote informed, diverse data representation 🤓 IHI GREG- EU project 🔍 Focuses on the testing & creation of guidelines on RWE. Guidance produced will be shared & used by decision makers in HTA & regulatory bodies. Explore: https://bit.ly/3FJil2h EUPATI is co-authoring a new course on RWE, leading a training session for all consortium members on patient involvement, coordinating a patient advisory group. Keep an 👁️ on the progress of this project 🙏 our session speakers Daniel Weibel from VAC4EU - Vaccine Monitoring Collaboration for Europe & Andreas Christodoulou EUPATI Cyprus and EUPATI team Finn McCartney, Aikaterini Charapa #PEOF2025 #RWE #RWD #WhyRWEMatters #PatientsShapeRWE #PatientsShapeRWD #EUPATI #VAC4EU
-